Foghorn Therapeutics Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
FHTX Nasdaq 8731 https://foghorntx.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Foghorn Therapeutics Inc.

Strength Seen in Foghorn Therapeutics (FHTX): Can Its 9.5% Jump Turn into More Strength? - Sep 16th, 2024 8:12 am
Insider Sale: Chief Scientific Officer Steven Bellon Sells 20,000 Shares of Foghorn ... - Sep 11th, 2024 11:02 pm
Foghorn Therapeutics Strengthens Leadership Team with Appointment of Anna Rivkin, Ph.D. as Chief Business Officer - Sep 3rd, 2024 11:00 am
Wall Street Analysts Think Foghorn Therapeutics (FHTX) Could Surge 81.16%: Read This Before Placing a Bet - Sep 2nd, 2024 1:55 pm
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences in September - Aug 28th, 2024 11:00 am
Zacks Industry Outlook Highlights Corcept, Amneal, Bioventus, Foghorn and Akebia - Aug 19th, 2024 10:10 am
Wall Street Analysts Believe Foghorn Therapeutics (FHTX) Could Rally 121.77%: Here's is How to Trade - Aug 16th, 2024 1:55 pm
5 Small Drug Stocks to Buy as Innovation Reaches Peak - Aug 16th, 2024 12:18 pm
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Tops Revenue Estimates - Aug 8th, 2024 12:10 pm
Foghorn Therapeutics Provides Second Quarter 2024 Financial and Corporate Update - Aug 8th, 2024 11:00 am
Flagship Pioneering Announces Appointment of Raj Panjabi as Senior Partner - Aug 6th, 2024 10:30 am
Institutional investors own a significant stake of 36% in Foghorn Therapeutics Inc. (NASDAQ:FHTX) - Jul 29th, 2024 11:06 am
Foghorn Therapeutics to Participate in Upcoming Investor Conferences in June - May 28th, 2024 11:00 am
Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline - May 22nd, 2024 10:21 pm
Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants - May 20th, 2024 11:58 am
Foghorn Therapeutics Inc. (NASDAQ:FHTX) Just Reported, And Analysts Assigned A US$11.67 Price Target - May 9th, 2024 10:31 am
Foghorn Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - May 7th, 2024 10:26 am
Foghorn Therapeutics Q1 2024 Earnings: Misses Analyst Revenue Projections Amidst Strategic ... - May 6th, 2024 12:32 pm
Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates - May 6th, 2024 12:10 pm
Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update - May 6th, 2024 11:00 am